Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by recurrent vascular thrombosis and miscarriages in the absence of known causes. Antibodies against phospholipid-binding proteins (aPL) are pathogenic players in both clotting and pregnancy APS manifestations. There is sound evidence that antibodies specific for beta2 glycoprotein I (beta 2GPI) trigger thrombotic and pregnancy complications by interacting with the molecule on the membranes of different cell types of the coagulation cascade, and in placenta tissues. In addition to the humoral response against beta 2GPI, both peripheral and tissue CD4(+) beta 2GPI-specific T cells have been reported in primary APS as well as in systemic lupus erythematosus (SLE)-associated APS. While adaptive immunity plays a clear role in APS, it is still debated whether innate immunity is involved as well. Acute systemic inflammation does not seem to be present in the syndrome, however, there is sound evidence that complement activation is crucial in animal models and can be found also in patients. Furthermore, neutrophil extracellular traps (NETs) have been documented in arterial and venous thrombi with different etiology, including clots in APS models. Keeping in mind that beta 2GPI is a pleiotropic glycoprotein, acting as scavenger molecule for infectious agents and apoptotic/damaged body constituents and that self-molecules externalized through NETs formation may become immunogenic autoantigens, we demonstrated beta 2GPI on NETs, and its ability to stimulate CD4(+)beta 2GPI-specific T cells. The aim of this review is to elucidate the role of beta 2GPI in the cross-talk between the innate and adaptive immunity in APS.

Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome / Grossi, Claudia; Capitani, Nagaja; Benagiano, Marisa; Baldari, Cosima Tatiana; Della Bella, Chiara; Macor, Paolo; Tedesco, Francesco; Borghi, Maria Orietta; Maugeri, Norma; D'Elios, Mario Milco; Meroni, Pier Luigi. - In: FRONTIERS IN IMMUNOLOGY. - ISSN 1664-3224. - ELETTRONICO. - 13:(2022), pp. 1076167.0-1076167.0. [10.3389/fimmu.2022.1076167]

Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome

Capitani, Nagaja;Benagiano, Marisa;Della Bella, Chiara;Tedesco, Francesco;D'Elios, Mario Milco;
2022

Abstract

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by recurrent vascular thrombosis and miscarriages in the absence of known causes. Antibodies against phospholipid-binding proteins (aPL) are pathogenic players in both clotting and pregnancy APS manifestations. There is sound evidence that antibodies specific for beta2 glycoprotein I (beta 2GPI) trigger thrombotic and pregnancy complications by interacting with the molecule on the membranes of different cell types of the coagulation cascade, and in placenta tissues. In addition to the humoral response against beta 2GPI, both peripheral and tissue CD4(+) beta 2GPI-specific T cells have been reported in primary APS as well as in systemic lupus erythematosus (SLE)-associated APS. While adaptive immunity plays a clear role in APS, it is still debated whether innate immunity is involved as well. Acute systemic inflammation does not seem to be present in the syndrome, however, there is sound evidence that complement activation is crucial in animal models and can be found also in patients. Furthermore, neutrophil extracellular traps (NETs) have been documented in arterial and venous thrombi with different etiology, including clots in APS models. Keeping in mind that beta 2GPI is a pleiotropic glycoprotein, acting as scavenger molecule for infectious agents and apoptotic/damaged body constituents and that self-molecules externalized through NETs formation may become immunogenic autoantigens, we demonstrated beta 2GPI on NETs, and its ability to stimulate CD4(+)beta 2GPI-specific T cells. The aim of this review is to elucidate the role of beta 2GPI in the cross-talk between the innate and adaptive immunity in APS.
2022
13
0
0
Goal 3: Good health and well-being
Grossi, Claudia; Capitani, Nagaja; Benagiano, Marisa; Baldari, Cosima Tatiana; Della Bella, Chiara; Macor, Paolo; Tedesco, Francesco; Borghi, Maria Orietta; Maugeri, Norma; D'Elios, Mario Milco; Meroni, Pier Luigi
File in questo prodotto:
File Dimensione Formato  
fimmu-13-1076167.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 1.66 MB
Formato Adobe PDF
1.66 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1355282
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 7
social impact